Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 550.0 | 29 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 359.0 | 42 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 479.5 | 60 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 20994.5 | 34 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 26517.0 | 39 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 31685.5 | 38 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 30248.0 | 40 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 10392.0 | 29 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 12307.0 | 43 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 16096.5 | 52 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | MMP-3 | 21907.0 | 27 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 375.5 | 22 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 428.0 | 27 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 252.5 | 36 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 117.0 | 29 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 311.0 | 47 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 467.0 | 45 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 304.5 | 42 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 315.0 | 33 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 566.5 | 40 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 888.0 | 51 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 1009.0 | 35 | |
N2759 | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 1331.5 | 38 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 570.5 | 36 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 1 | MMP-3 | 474.0 | 35 |